Palatin Technologies (NYSE:PTN) Now Covered by Wall Street Zen

Wall Street Zen assumed coverage on shares of Palatin Technologies (NYSE:PTN) in a report released on Tuesday morning. The firm issued a sell rating on the stock.

Palatin Technologies Trading Down 44.6%

Shares of PTN stock opened at $0.09 on Tuesday. Palatin Technologies has a 52 week low of $0.09 and a 52 week high of $2.48. The firm has a market cap of $2.45 million, a PE ratio of -0.06 and a beta of 0.94.

About Palatin Technologies

Palatin Technologies, Inc, a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company’s lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder.